Tackling multiple sclerosis

Nature. 2002 Nov 7;420(6911):39-40. doi: 10.1038/420039a.
No abstract available

Publication types

  • News
  • Comment

MeSH terms

  • Animals
  • Antigen Presentation / drug effects
  • Atorvastatin
  • Central Nervous System Diseases / drug therapy
  • Central Nervous System Diseases / immunology
  • Encephalomyelitis, Autoimmune, Experimental / drug therapy*
  • Encephalomyelitis, Autoimmune, Experimental / immunology
  • Heptanoic Acids / pharmacology
  • Heptanoic Acids / therapeutic use*
  • Histocompatibility Antigens Class II / genetics
  • Histocompatibility Antigens Class II / immunology
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Mice
  • Multiple Sclerosis / drug therapy*
  • Pyrroles / pharmacology
  • Pyrroles / therapeutic use*
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology

Substances

  • Heptanoic Acids
  • Histocompatibility Antigens Class II
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyrroles
  • Atorvastatin